Molecular Biology Techniques

Wenham PR . DNA-based techniques in clinical biochemistry: A beginner's guide to theory and practice. Ann Clin Biochem 1992; 29: 598–624.

Health and Safety Executive Advisory Committee on Genetic Manipulation (Genetic Manipulation Advisory Group). Genetic manipulation regulations—guidance on regulations. Health and Safety Executive. London: HMSO, 1989.

Evans MR Read CA . ³²P, ³³P, and 35S: selecting a label for nucleic acid analysis. Nature 1992; 358: 520–1.

Kricka LJ (ed). Non-isotopic DNA Probe Techniques. London: Academic Press, 1991.

Yap EP-H Lo YM-D Cooper K Fleming KA McGee JO'D . Exclusion of false positive PCR viral diagnosis by single strand conformational polymorphism. Lancet 1992; 340: 736.

Lo YM-D Lo ES-F Patel P Tse CH Fleming KA . Heteroduplex formation as a means of exclude contamination in virus detection using PCR. Nucleic Acid Res 1991; 19: 6653.

Liu J Lissens W Devroey P Van Steirteghem Liebaers I . Efficiency and accuracy of polymerase-chain reaction assay for cystic fibrosis allele ΔF508 in single cells. Lancet 1992; 339: 1190–2.

Bloch W . A biochemical perspective of the polymerase chain reaction. Biochemistry 1991; 30: 2735–47.

Kwok S Higuchi R . Avoiding false positives with PCR. Nature 1989; 339: 327.

Kitchin PA Szotyoin Z Fromholc C Almond N . Avoidance of false positives with PCR. Nature 1989; 344: 201.

Cimino GD Mitchetto K Isaacs ST Zhu YS . More false positives in PCR. Nature 1990; 345: 773.

Sarkar G Sommer SS . More light on PCR contamination. Nature 1990; 347: 340.

Beaudet AL . Carrier screening for cystic fibrosis. Am J Hum Genet 1990; 47: 603–5.

Editorial. Screening for cystic fibrosis. Lancet 1992; 340: 209–10.

The Cystic Fibrosis Genetic Analysis Consortium. Worldwide survey of the ΔF508 mutation. Am J Hum Genet 1990; 47: 354–9.

Picci L Anglani F Scarpa M Zachello F . Screening for cystic fibrosis gene mutations by multiplex DNA amplification. Hum Genet 1992; 88: 552–6.

Collins FS . Cystic fibrosis: Molecular biology and therapeutic implications. Science 1992; 256: 774–9.

Chapman M . Invited editorial: Predictive testing for adult onset genetic disease: Ethical and legal implications of the use of linkage analysis for Huntingdon disease. Am J Hum Genet 1990; 47: 1–3.

Fost N . Ethical implications of screening asymptomatic individuals. FASEB J 1992; 6: 2783–90.